recombinant protein COVID-19 vaccines (two formulations)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for recombinant protein COVID-19 vaccines (two formulations), covering 2023-04-10 to 2023-04-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines [Phase 3]